• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket

    12/21/23 7:46:57 AM ET
    $ACON
    $ATAK
    $BB
    $DUNE
    Medical Specialities
    Health Care
    Blank Checks
    Finance
    Get the next $ACON alert in real time by email

    Shares of BlackBerry Limited (NYSE:BB) moved lower in pre-market trading following the release of third-quarter results.

    BlackBerry reported quarterly earnings of 1 cent per share which exceeded the Street's estimate of losses of 3 cents per share, according to Benzinga Pro. The company also said it sees fourth-quarter revenue of $150 million to $159 million.

    BlackBerry shares fell 5.4% to $3.88 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Infrared Cameras Holdings Inc (NASDAQ:MSAI) rose 213% to $8.20 in pre-market trading after falling over 61% on Wednesday.
    • Mobile Global Esports Inc.(NASDAQ:MGAM) gained 53.4% to $0.4294 in pre-market trading after falling 4% on Wednesday.
    • Mesoblast Limited (NASDAQ:MESO) shares gained 32.1% to $1.40 in pre-market trading. Mesoblast recently reported placement and accelerated non-renounceable entitlement offer to raise up to A$97 million.
    • ParaZero Technologies Ltd. (NASDAQ:PRZO) shares surged 30.9% to $1.61 in pre-market trading. ParaZero shares jumped over 75% on Wednesday after the company announced the successful completion of its safety solution development for a Fortune 500 leading global automotive manufacturer's proprietary drone program.
    • 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) shares rose 27.4% to $1.49 in pre-market trading after jumping 36% on Wednesday.
    • Aurora Technology Acquisition Corp.. (NASDAQ:ATAK) shares gained 26.1% to $5.56 in pre-market trading after falling 15% on Wednesday.
    • Edgio, Inc. (NASDAQ:EGIO) shares climbed 25% to $0.4313 in pre-market trading after declining around 10% on Wednesday.
    • PetVivo Holdings, Inc. (NASDAQ:PETV) shares rose 23.2% to $1.01 in pre-market trading.
    • Inovio Pharmaceuticals, Inc. (NASDAQ:INO) gained 14% to $0.44 in pre-market trading.
    • Micron Technology, Inc. (NASDAQ:MU) rose 5.7% to $83.21 in pre-market trading after the company reported mixed first-quarter financial results and issued strong guidance.

    Losers

    • Polished.com Inc. (NYSE:POL) shares fell 40.3% to $4.54 in pre-market trading after jumping 618% on Wednesday.
    • Nogin, Inc. (NASDAQ:NOGN) shares fell 28.6% to $0.0800 in pre-market trading after dipping over 30% on Wednesday.
    • Aclarion, Inc. (NASDAQ:ACON) shares fell 16.9% to $0.2899 in pre-market trading. Aclarion shares rose over 19% on Wednesday after the company was granted U.S. patent #11844601 for "MR SPECTROSCOPY SYSTEM FOR DIAGNOSING PAINFUL AND NON-PAINFUL INTERVERTEBRAL DISCS (Severe Low Back Pain)."
    • Dune Acquisition Corporation (NASDAQ:DUNE) fell 15.6% to $3.90 in pre-market trading after gaining 6% on Wednesday.
    • Gaucho Group Holdings, Inc. (NASDAQ:VINO) fell 13.3% to $0.49 in pre-market after jumping 20% on Wednesday.
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) fell 13.3% to $0.0104 in pre-market trading. Esports Entertainment shares fell 41% on Wednesday after the company announced a 1-for-400 reverse stock split.
    • Passage Bio, Inc. (NASDAQ:PASG) shares fell 9.8% to $0.7344 in pre-market trading after gaining 7% on Wednesday. Passage Bio announced initial safety and biomarker data from three Cohort 1 patients in the ongoing global Phase 1/2 upliFT-D clinical trial evaluating PBFT02, an adeno-associated virus (AAV)-delivery gene therapy for frontotemporal dementia (FTD) with granulin (GRN) mutations.
    • InMed Pharmaceuticals Inc. (NASDAQ:INM) shares fell 9.4% to $0.33 in pre-market trading.
    • iCoreConnect Inc. (NASDAQ:ICCT) shares fell 8.7% to $1.56 in pre-market trading.

     

    Now Read This: Top 4 Health Care Stocks That May Crash This Month

    Get the next $ACON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACON
    $ATAK
    $BB
    $DUNE

    CompanyDatePrice TargetRatingAnalyst
    Micron Technology Inc.
    $MU
    2/17/2026$380.00 → $450.00Buy
    Needham
    Passage Bio Inc.
    $PASG
    2/10/2026$21.00Buy
    Chardan Capital Markets
    Micron Technology Inc.
    $MU
    1/23/2026$350.00 → $500.00Buy
    HSBC Securities
    Micron Technology Inc.
    $MU
    1/22/2026Outperform
    William Blair
    Micron Technology Inc.
    $MU
    1/20/2026$300.00 → $450.00Buy
    TD Cowen
    Micron Technology Inc.
    $MU
    1/16/2026$275.00 → $450.00Overweight
    Barclays
    Micron Technology Inc.
    $MU
    1/15/2026$425.00Outperform
    RBC Capital Mkts
    Micron Technology Inc.
    $MU
    1/7/2026$300.00 → $400.00Buy
    UBS
    More analyst ratings

    $ACON
    $ATAK
    $BB
    $DUNE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner A.L. Sarroff Fund, Llc converted options into 974,809 shares and bought $77,999 worth of shares (154,840 units at $0.50) (SEC Form 4)

    4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

    1/16/26 4:38:39 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    Large owner A.L. Sarroff Fund, Llc bought $485,355 worth of shares (718,358 units at $0.68) and converted options into 4,033,209 shares (SEC Form 4)

    4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

    1/16/26 4:38:14 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    Large owner A.L. Sarroff Fund, Llc converted options into 164,340 shares and bought $100,001 worth of shares (111,112 units at $0.90) (SEC Form 4)

    4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

    1/16/26 4:37:39 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    $ACON
    $ATAK
    $BB
    $DUNE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Scientific Officer Humeau Laurent

    4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)

    3/5/26 4:55:40 PM ET
    $INO
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Chief Executive Officer Shea Jacqueline Elizabeth

    4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)

    3/5/26 4:55:11 PM ET
    $INO
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Chief Medical Officer Sumner Michael John

    4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)

    3/5/26 4:54:42 PM ET
    $INO
    Medical/Dental Instruments
    Health Care

    $ACON
    $ATAK
    $BB
    $DUNE
    SEC Filings

    View All

    Passage Bio Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement

    8-K - Passage BIO, Inc. (0001787297) (Filer)

    3/10/26 7:15:33 AM ET
    $PASG
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    InMed Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer)

    3/9/26 7:43:44 AM ET
    $INM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    InMed Pharmaceuticals Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer)

    3/6/26 4:58:07 PM ET
    $INM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACON
    $ATAK
    $BB
    $DUNE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham reiterated coverage on Micron with a new price target

    Needham reiterated coverage of Micron with a rating of Buy and set a new price target of $450.00 from $380.00 previously

    2/17/26 7:06:48 AM ET
    $MU
    Semiconductors
    Technology

    Chardan Capital Markets resumed coverage on Passage BIO with a new price target

    Chardan Capital Markets resumed coverage of Passage BIO with a rating of Buy and set a new price target of $21.00

    2/10/26 6:56:48 AM ET
    $PASG
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    HSBC Securities reiterated coverage on Micron with a new price target

    HSBC Securities reiterated coverage of Micron with a rating of Buy and set a new price target of $500.00 from $350.00 previously

    1/23/26 10:28:05 AM ET
    $MU
    Semiconductors
    Technology

    $ACON
    $ATAK
    $BB
    $DUNE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    INOVIO to Participate in Upcoming Scientific Conferences

    PLYMOUTH MEETING, Pa., March 9, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that it will participate in the following scientific conferences: Eurogin HPV Conference (Vienna, Austria)Date: Thursday, March 19Time: 8:00 AM CETPresentation: DNA Immunotherapy INO-3107 Demonstrates Long-Term Surgical Intervention Reduction in HPV-6 & 11 RRPWorld Vaccine Congress DC (Washington, DC)Date: Monday, Marc

    3/9/26 8:05:00 AM ET
    $INO
    Medical/Dental Instruments
    Health Care

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    INOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

    PLYMOUTH MEETING, Pa., March 5, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancers, and infectious diseases, today announced that its fourth quarter and full year 2025 financial results will be released after the market close on March 12, 2026. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss the financial results and provide a general business update. The live webcast will be available

    3/5/26 4:05:00 PM ET
    $INO
    Medical/Dental Instruments
    Health Care

    $ACON
    $ATAK
    $BB
    $DUNE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Mesoblast Limited

    SC 13G/A - MESOBLAST LTD (0001345099) (Subject)

    12/16/24 12:08:07 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/12/24 9:44:00 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/5/24 4:08:58 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    $ACON
    $ATAK
    $BB
    $DUNE
    Leadership Updates

    Live Leadership Updates

    View All

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    ParaZero Strengthens Global Sales Leadership with Appointment of Bat-Sheva Noy as VP

    Kfar Saba, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (NASDAQ:PRZO) (the "company" or "ParaZero"), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, recently announced the appointment of Bat-Sheva Noy as its new Vice President of Global Sales. Ms. Noy brings more than 20 years of extensive commercial and leadership experience, with particular expertise in strategic planning, market access, and leading cross-functional teams. Most recently, from 2020 to 2025, she served as the Business Unit Lead for Rare Diseases at Pfizer Israel ((a subsidiary of Pfizer Inc., NYSE:PFE). In that

    3/4/26 8:32:00 AM ET
    $PFE
    $PRZO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Military/Government/Technical
    Industrials

    Military UAV Sector Forecast to Surpass $40+ Billion as Modern Warfare Evolves

    NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Unmanned aerial vehicles (UAVs), commonly known as drones, have become a transformative technology in modern defense and military operations, reshaping strategies from reconnaissance to precision strike capabilities. Military drones offer armed forces enhanced situational awareness, reduced risk to personnel, and cost-efficient mission profiles across surveillance, target acquisition, logistics, and electronic warfare. As autonomous systems incorporating artificial intelligence and advanced sensor suites continue to mature, they are increasingly integral to networked battlefield operations and force multiplie

    2/19/26 8:30:00 AM ET
    $NOC
    $PRZO
    $UAVS
    Industrial Machinery/Components
    Industrials
    Military/Government/Technical
    Aerospace

    $ACON
    $ATAK
    $BB
    $DUNE
    Financials

    Live finance-specific insights

    View All

    INOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

    PLYMOUTH MEETING, Pa., March 5, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancers, and infectious diseases, today announced that its fourth quarter and full year 2025 financial results will be released after the market close on March 12, 2026. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss the financial results and provide a general business update. The live webcast will be available

    3/5/26 4:05:00 PM ET
    $INO
    Medical/Dental Instruments
    Health Care

    Micron Technology to Report Fiscal Second Quarter Results on March 18, 2026

    BOISE, Idaho, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (NASDAQ:MU) announced today that it will hold its fiscal second quarter earnings conference call on Wednesday, Mar. 18, 2026, at 2:30 p.m. Mountain time. The call will be webcast live at http://investors.micron.com/. Webcast replays of presentations can be accessed from Micron's Investor Relations website for approximately one year after the call. About Micron Technology, Inc.  Micron Technology, Inc. is an industry leader in innovative memory and storage solutions transforming how the world uses information to enrich life for all. With a relentless focus on our customers, technology leadership, and manufacturing and

    2/24/26 4:01:00 PM ET
    $MU
    Semiconductors
    Technology

    PetVivo Reports Results for Third Quarter and First Nine Months of Fiscal 2026

    MINNEAPOLIS, MN, US, Feb. 17, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV, OTC ID: PETVW)), and its wholly owned subsidiaries PetVivo Animal Health and PetVivo AI, a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, reported financial and operational results for the third quarter and first nine months of its fiscal year 2026 ended December 31, 2025. The company will hold a conference call today at 5:00 p.m. Eastern time to discuss the results and provide a business update, followed by a question-and-answer session (see dial-in information below). Fiscal Q3 Operational Highlights Signed an exclusive 10-ye

    2/17/26 4:30:00 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care